-
Mashup Score: 1Embolization Evolution - 1 day(s) ago
In This Issue Parag J. Patel, MD, summarizes our latest feature on the embolization evolution, where expert operators share their technical tips and opinions and offer hints at what lies ahead.
Source: www.linkedin.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1
March 6, 2025—Reflow Medical, Inc., which is headquartered in San Clemente, California, announced the opening of its European subsidiary in Land
Source: citoday.comCategories: General Medicine News, CardiologistsTweet-
RT @cardiacinterv: Reflow Medical Expands With New European Subsidiary | @reflowmedical https://t.co/RaGQKnaYzG
-
-
Mashup Score: 0
March 6, 2025—Inari Medical announced the launch of its Artix thrombectomy system for arterial thromboembolism. According to the company, which
Source: evtoday.comCategories: General Medicine News, CardiologistsTweet-
Stryker’s Inari Medical Launches Artix Thrombectomy System | @StrykerComm @InariMedical https://t.co/GtUbVoXLxu
-
-
Mashup Score: 1Philips Recalls, Removes, and Discontinues Distribution of Tack Endovascular System - Endovascular Today - 5 day(s) ago
March 6, 2025—The FDA advised this week that Philips is recalling the Tack endovascular systems because of challenges experienced by customers d
Source: evtoday.comCategories: General Medicine News, CardiologistsTweet-
Philips Recalls, Removes, and Discontinues Distribution of Tack Endovascular System | @Philips https://t.co/yz2gMqX4Ma
-
-
Mashup Score: 0J&J MedTech Launches Cereglide 92 Catheter to Treat Acute Ischemic Stroke - Endovascular Today - 25 day(s) ago
February 14, 2024—Johnson & Johnson MedTech recently launched their Cereglide 92 catheter system for the treatment of acute ischemic stroke.
Source: evtoday.comCategories: General Medicine News, CardiologistsTweet-
J&J MedTech Launches Cereglide 92 Catheter to Treat Acute Ischemic Stroke | @JNJMedTech https://t.co/uFKkc8BP02
-
-
Mashup Score: 0CVRx Barostim Demonstrates Reduction in Health Care Use in Real-World Data - Endovascular Today - 26 day(s) ago
February 12, 2025—CVRx, Inc. announced new real-world evidence demonstrating that use of the company’s Barostim implant was associated wit
Source: evtoday.comCategories: General Medicine News, CardiologistsTweet-
CVRx Barostim Demonstrates Reduction in Health Care Use in Real-World Data | @CVRx_Barostim https://t.co/7oXFj8zzM3
-
-
Mashup Score: 0Guerbet’s Lipiojoint Liquid Embolic Granted FDA Breakthrough Device Status - Endovascular Today - 29 day(s) ago
February 10, 2025—Guerbet announced that its Lipiojoint transient liquid embolic agent received Breakthrough Device status from the United State
Source: evtoday.comCategories: General Medicine News, CardiologistsTweet-
Guerbet’s Lipiojoint Liquid Embolic Granted FDA Breakthrough Device Status | @GuerbetGroup https://t.co/cOiDIJ6D2o
-
-
Mashup Score: 10Digital Health in DVT: What Would Truly Help Guide Care and Research? - Endovascular Today - 29 day(s) ago
Insights into the digital tools that can help improve patient engagement and advance understanding in deep vein thrombosis care.
Source: evtoday.comCategories: General Medicine News, CardiologistsTweet-
We spoke with Christiana Salami, MS; Bedros Taslakian, MD; Osman Ahmed, MD; Ezana Azene, MD; and Dania Daye, MD, and asked them to provide insights about digital health in DVT and what would truly help guide care and research. https://t.co/RudJROiRmj
-
-
Mashup Score: 0Arsenal’s EMBO-02 Study of NeoCast for cSDH Treatment Enrolls Initial Cohort - Endovascular Today - 1 month(s) ago
February 6, 2025—Arsenal Medical announced the completion of the initial cohort enrollment in the EMBO-02 clinical study of the company’s
Source: evtoday.comCategories: General Medicine News, CardiologistsTweet-
Arsenal’s EMBO-02 Study of NeoCast for cSDH Treatment Enrolls Initial Cohort | @ArsenalMedical https://t.co/pZww8CIS1c
-
-
Mashup Score: 0Medtronic’s DiVERT Stroke Study Evaluated Sex-based Disparities in Post-stroke Cardiac Care - Endovascular Today - 1 month(s) ago
February 6, 2025—Medtronic announced that new findings from the company-sponsored DiVERT Stroke clinical study showed women spent less time in t
Source: evtoday.comCategories: General Medicine News, CardiologistsTweet-
Medtronic’s DiVERT Stroke Study Evaluated Sex-based Disparities in Post-stroke Cardiac Care https://t.co/Acz7eeWJxZ
-
🌟 New Issue 🌟 Our latest issue looks at the evolution of hashtag#embolization with expert operators sharing their technical tips and opinions and offering hints at what lies ahead. https://t.co/T3hC7wYdnF